Reuters logo
4 个月前
BRIEF-Valeant announces pricing for Siliq
2017年4月21日 / 中午11点44分 / 4 个月前

BRIEF-Valeant announces pricing for Siliq

April 21 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant's patient access and pricing committee announces pricing for Siliq(brodalumab) as the lowest priced injectable biologic for moderate-to-severe plaque psoriasis

* Valeant - sales and marketing of Siliq are expected to commence in U.S. During second half of 2017

* Valeant - decided to list Siliq injection, at $3,500 per month

* Valeant - Siliq will also be included in company's patient access program to further offer financial support and access to patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below